Cristina D Peterson

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 13

Top Topics

Neuropathic Pain

Angiotensin Converting Enzyme

Top Venues

The Journal of pharmacology and experimental therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Christina M Larson, Cecilia Barajas, Kelley F Kitto, George L Wilcox, Carolyn A Fairbanks, Cristina D Peterson
Development of opioid analgesic tolerance in rat to extended-release buprenorphine formulated for laboratory subjects. PloS one 19 (3) (2024)
Mayur K Ladumor, Catharine A Mielnik, Cristina D Peterson, Freeborn Rwere, Eric R Gross
The JPET Editorial Fellowship: Opening the Blinds to the Peer Review and Editorial Process. The Journal of pharmacology and experimental therapeutics 389 (2) (2024)
Mayur K Ladumor, Catharine A Mielnik, Cristina D Peterson, Freeborn Rwere, Eric R Gross
The JPET Editorial Fellowship: Opening the Blinds to the Peer Review and Editorial Process. The Journal of pharmacology and experimental therapeutics 389 (2) (2024)
Mayur K Ladumor, Catharine A Mielnik, Cristina D Peterson, Freeborn Rwere, Eric R Gross
The JPET Editorial Fellowship: Opening the Blinds to the Peer Review and Editorial Process. The Journal of pharmacology and experimental therapeutics 389 (2) (2024)
Mayur K Ladumor, Catharine A Mielnik, Cristina D Peterson, Freeborn Rwere, Eric R Gross
The JPET Editorial Fellowship: Opening the Blinds to the Peer Review and Editorial Process. The Journal of pharmacology and experimental therapeutics 389 (2) (2024)
Andrea Cignarella, Cristina D Peterson
Mechanistic Chronopharmacology: Preclinical Modeling of an SGLT2 Inhibitor in Preventing Painful Diabetic Neuropathy. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Christina M Larson, Cecilia Barajas, Kelley F Kitto, George L Wilcox, Carolyn A Fairbanks, Cristina D Peterson
Development of opioid analgesic tolerance in rat to extended-release buprenorphine formulated for laboratory subjects. PloS one 19 (3) (2024)
Mayur K Ladumor, Catharine A Mielnik, Cristina D Peterson, Freeborn Rwere, Eric R Gross
The JPET Editorial Fellowship: Opening the Blinds to the Peer Review and Editorial Process. The Journal of pharmacology and experimental therapeutics 389 (2) (2024)
Mayur K Ladumor, Catharine A Mielnik, Cristina D Peterson, Freeborn Rwere, Eric R Gross
The JPET Editorial Fellowship: Opening the Blinds to the Peer Review and Editorial Process. The Journal of pharmacology and experimental therapeutics 389 (2) (2024)
Andrea Cignarella, Cristina D Peterson
Mechanistic Chronopharmacology: Preclinical Modeling of an SGLT2 Inhibitor in Preventing Painful Diabetic Neuropathy. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Christina M Larson, Cecilia Barajas, Kelley F Kitto, George L Wilcox, Carolyn A Fairbanks, Cristina D Peterson
Development of opioid analgesic tolerance in rat to extended-release buprenorphine formulated for laboratory subjects. PloS one 19 (3) (2024)
Benjamin M Clements, Cristina D Peterson, Kelley F Kitto, Lukas D Caye, George L Wilcox, Carolyn A Fairbanks
Biodistribution of Agmatine to Brain and Spinal Cord Following Systemic Delivery . The Journal of pharmacology and experimental therapeutics (2023)
Cristina D Peterson, Kelley F Kitto, Harsha Verma, Kelsey Pflepsen, Eric Delpire, George L Wilcox, Carolyn A Fairbanks
Agmatine requires GluN2B-containing NMDA receptors to inhibit the development of neuropathic pain. Molecular pain 17 (2022)